Navigation Links
AAPCC Issues Statement on Decision of Procter & Gamble to Redesign Tide Pods Packaging
Date:7/12/2013

Alexandria, VA (PRWEB) July 12, 2013

On July 11, Procter & Gamble announced it has redesigned the packaging of its single-load highly concentrated laundry detergent packets. In response, AAPCC President Marsha Ford, MD, FACMT, FACEP, issued the following statement:

“We have learned that Procter & Gamble has decided to redesign the packaging of Tide Pods, its single-load highly concentrated laundry detergent packets. The American Association of Poison Control Centers and America’s poison centers commend Procter and Gamble for this decision and call on other manufacturers of similar products to do the same.

“The Procter & Gamble product had been sold in clear packages in which the colorful packets were easily visible to children. Making the packaging opaque hopefully will help reduce the temptation of children to get into the product.

“In May 2012, poison centers first alerted the public about children 5 and younger becoming very ill after exposure to single-load laundry packets sold by several manufacturers. Since January 1 of this year, poison centers have managed nearly 5,000 cases of children 5 and younger exposed to laundry packets of various brands.

“New packaging alone won’t protect young children from these products. It’s also important for parents and caregivers always to keep laundry detergents locked up high and out of the reach of children, to follow the instructions on the product label, and to call their local poison center at 1-800-222-1222 immediately if they suspect a child has swallowed some of the detergent or gotten it into his or her eyes.”

More information about single-load laundry detergent packets is available on the AAPCC website at http://www.aapcc.org/alerts/laundry-detergent-packets/.

For more information, the media may contact Loreeta Canton, director of public relations and member services, at 703.894.1858 or canton(at)aapcc(dot)org; or Brett Schuster, communications associate, at 703.894.1858 or Schuster(at)aapcc(dot)org.

About the American Association of Poison Control Centers:

The AAPCC supports the nation’s 57 poison centers in their efforts to prevent and treat poison exposures. Poison centers offer free, confidential medical advice 24 hours a day, seven days a week through the Poison Help Line at 1-800-222-1222. This service provides a primary resource for poisoning information and helps reduce costly emergency department visits through in-home treatment.

To learn more, visit http://www.aapcc.org, like us on Facebook, follow us on Twitter, or read our blog at aapcc.wordpress.com. To join your voice with other poison center supporters, register for the AAPCC advocacy network at http://www.capwiz.com/aapcc – click on “Action E-List.”

– 30 –

Read the full story at http://www.prweb.com/releases/2013/7/prweb10923661.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AAPCC Issues Statement on Decision of Urban Outfitters to Stop Selling Prescription-Themed Products
2. UCSF chancellor issues call-to-arms to patient advocates
3. Radiologists rank themselves as less than competent on health policy issues
4. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
5. FDA Issues Multiple Sclerosis Drug Alert
6. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
7. U.S. Task Force Issues Blood Pressure Guidelines
8. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
9. Cheaper drug could lead to serious eye issues
10. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
11. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... so many different solutions on the market, it is easy to start feeling ... Premier Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Bioness, Inc., ... therapies, today announced the first series of successful StimRouter ... at Radboud University Medical Center (Nijmegen, Netherlands ... ( Cork, Ireland ), and Kliniek Park ... the successful launch continuing, Bioness plans to further support ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: